Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Advisory Committee on Immunization Practices (ACIP)


Section Navigation
			
			CDC Home








ACIP Shared Clinical Decision-Making Recommendations						Print
																Related Pages
										**On This Page**
			What are ACIP’s current shared clinical decision-making recommendations that appear on the immunization schedules?How do shared clinical decision-making recommendations differ from routine, catch-up, and risk-based immunization recommendations?When does ACIP make shared clinical decision-making recommendations?Who is considered a health care provider with regard to shared clinical decision-making recommendations?Which patients should providers discuss shared clinical decision-making recommendations with?What resources are available for providers who want to implement these recommendations?Are shared clinical decision-making recommendations covered by private insurers?
		
Question and Answer iconFrequently Asked Questions
These frequently asked questions (FAQs) are intended to provide clarity on the Advisory Committee on Immunization Practices’ (ACIP) shared clinical decision-making recommendations and guidance and implementation considerations for these recommendations.
What are ACIP’s current shared clinical decision-making recommendations that appear on the immunization schedules?
ACIP has five recommendations for vaccination based on shared clinical decision-making that appear on the tables and/or notes of the immunization schedules.
Respiratory syncytial virus (RSV) vaccination for adults aged 60 years and older
Meningococcal B (MenB) vaccination for adolescents and young adults aged 16–23 years
Hepatitis B (HepB) vaccination for adults aged 60 years and older with diabetes mellitus
Human papillomavirus (HPV) vaccination for adults aged 27–45 years
Pneumococcal conjugate vaccination (PCV20) for adults aged 65 years and older who have completed the recommended vaccine series with both PCV13 (at any age) and PPSV23 (which was administered at age ≥65 years)
How do shared clinical decision-making recommendations differ from routine, catch-up, and risk-based immunization recommendations?
Unlike routine, catch-up, and risk-based recommendations, shared clinical decision-making vaccinations are not recommended for everyone in a particular age group or everyone in an identifiable risk group. Rather, shared clinical decision-making recommendations are individually based and informed by a decision process between the health care provider and the patient or parent/guardian.
The key distinction between routine, catch-up, and risk-based recommendations and shared clinical decision-making recommendations is the default decision to vaccinate. For routine, catch-up, and risk-based recommendations, the default decision should be to vaccinate the patient based on age group or other indication, unless contraindicated. For shared clinical decision-making recommendations, there is no default—the decision about whether or not to vaccinate may be informed by the best available evidence of who may benefit from vaccination; the individual’s characteristics, values, and preferences; the health care provider’s clinical discretion; and the characteristics of the vaccine being considered.  There is not a prescribed set of considerations or decision points in the decision-making process.
Top of Page
When does ACIP make shared clinical decision-making recommendations?
Generally, ACIP makes shared clinical decision-making recommendations when individuals may benefit from vaccination, but broad vaccination of people in that group is unlikely to have population-level impacts.
For example, in June 2019, ACIP recommended shared clinical decision-making for HPV vaccination of adults aged 27–45 years. HPV acquisition generally occurs soon after first sexual activity. Vaccine effectiveness is lower in older age groups because of prior infections and lower risk of exposure (for example, among persons who are in a long-term, mutually monogamous sexual partnership). ACIP recommended shared clinical decision-making rather than catch-up vaccination because most adults in this age group would have no or minimal benefits from vaccination. However, some individuals who are not already immune to HPV through vaccination or natural infection (e.g., a previously unvaccinated person who has never had sex) and who might be at risk for acquiring a new HPV infection in the future (e.g., plans to have sex with a new partner in the future) might benefit from vaccination.
Who is considered a health care provider with regard to shared clinical decision-making recommendations?
In this context, CDC defines a health care provider as anyone who provides or administers vaccines: primary care physicians, specialists, physician assistants, nurse practitioners, registered nurses, and pharmacists.
Top of Page
Which patients should providers discuss shared clinical decision-making recommendations with?
It’s up to the provider. Some health care providers may choose to discuss immunizations recommended for shared clinical decision-making with all or most of their patients who could receive it, while some providers may be more selective when discussing these immunizations with their patients. Health care providers should also be receptive to patient-initiated conversations about these immunizations.
What resources are available for providers who want to implement these recommendations?
ACIP and CDC provide resources to help providers implement these recommendations.
ACIP recommendations
Health care providers can find information on ACIP’s recommendations on the ACIP Vaccine Recommendations and  Guidelines page.
For every ACIP recommendation, CDC publishes a policy note in the *Morbidity and Mortality Weekly Report*(MMWR), which provides background and considerations on each recommendation.
CDC resources for shared clinical decision-making
CDC will also develop vaccine-specific guidance to help clinicians understand and apply shared clinical decision-making recommendations.
Healthcare Providers: RSV Vaccination for Adults 60 Years of Age and Over
HPV Vaccination for Adults Aged 27-45 Years
Meningococcal B Vaccination
PCV20 Vaccination for Adults 65 Years or OlderTop of Page
Are shared clinical decision-making recommendations covered by private insurers?
Under the Affordable Care Act and its implementing regulations, ACIP recommendations that have been adopted by CDC “with respect to the individual involved” and are “listed on the Immunization Schedules of the Centers for Disease Control and Prevention” generally are required to be covered by group health plans and health insurance issuers offering group or individual health insurance coverage without imposing any cost-sharing requirements (such as a copayment, coinsurance, or deductible).[1] This coverage requirement includes shared clinical decision-making recommendations when they have been adopted by CDC and are listed on the immunization schedules.
Footnotes
Section 2713(a)(2) of the Public Health Service Act, as added by section 1001 of the Affordable Care Act, implemented at 26 CFR 54.9815-2713(a)(1)(ii), 29 CFR 2590.715-2713(a)(1)(ii), and 45 CFR 147.130(a)(1)(ii). This requirement does not apply to grandfathered health plan coverage under section 1251 of the Affordable Care Act, implemented at 26 CFR 54.9815-1251, 29 CFR 2590.715-1272, and 45 CFR 147.140.
Top of Page
							
					
							Last Reviewed:  September 29, 2023						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeACIP Home
Meeting Information
Committee Informationplus icon
Role of the ACIP in CDC’s Vaccine Recommendations
Charter
Economics Studies
Committee Membersplus icon
ACIP Membership Roster
Apply for ACIP Membership
Work Groupsplus icon
VaST Reportsplus icon
June 28, 2021
May 24, 2021
May 17, 2021
March 29, 2021
Recommendationsplus icon
Shared Clinical Decision-Making Recommendations
Evidence Based Recommendationsplus icon
About GRADE
Grade Evidence Tables
Evidence to Recommendations Frameworks Vaccines & ImmunizationsImmunization SchedulesVFC ResolutionsVaccine Information Statements (VISs)
  1600 Clifton Road, N.E., Mailstop A27
Atlanta, GA 30329-4027acip@cdc.gov


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue